← All trials
NCT02002156
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2014
- Primary completion
- Aug 1, 2016
- Completion date
- Aug 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 28
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of OxfordLead sponsor
Drugs studied
- bacille calmette-guerin
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- menitorix
- pneumococcal 13-valent conjugate vaccine
- Measles, Mumps and Rubella Vaccine, Live
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- human rotavirus, live attenuated
- Monovalent group C meningococcal vaccine
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.